Does Olaplex cause hair loss? This question has gained significant attention following consumer reports and a high-profile US class action lawsuit. Olaplex is a professional bond-building hair care brand widely used in UK salons and at home, marketed to repair chemically damaged hair. While many users report positive results, others have described increased shedding, scalp irritation, and texture changes. This article examines the available evidence, UK regulatory position, and reported side effects — and explains when hair loss warrants assessment by a GP or dermatologist rather than being attributed to a cosmetic product.
Summary: There is currently no robust, independent clinical evidence or UK regulatory ruling confirming that Olaplex causes hair loss, though some users report increased shedding and scalp irritation.
- Olaplex's active ingredient, bis-aminopropyl diglycol dimaleate, is designed to repair disulphide bonds in the hair shaft — it does not act on the scalp or hair follicle.
- No UK regulatory body (OPSS, NHS, or MHRA) has issued a formal safety warning linking Olaplex to hair loss.
- A 2022 US class action lawsuit raised public concern, but legal proceedings do not constitute scientific proof of causation.
- Lilial, a fragrance ingredient previously in some Olaplex products, was banned in UK and EU cosmetics from March 2022 due to reproductive toxicity — not hair loss.
- Common causes of hair loss such as telogen effluvium, thyroid disorders, and iron deficiency should be excluded before attributing shedding to any cosmetic product.
- Persistent or distressing hair loss should be assessed by a GP, who can arrange blood tests and refer to an NHS dermatologist if needed.
Table of Contents
What Is Olaplex and How Does It Work on Hair?
Olaplex uses bis-aminopropyl diglycol dimaleate to repair disulphide bonds in the hair shaft, targeting structural damage from bleaching and colouring rather than acting on the scalp or follicle.
Olaplex is a professional hair care brand that became widely popular in salons and among consumers for its claim to repair and strengthen chemically damaged hair. The brand's core technology centres on a patented active ingredient called bis-aminopropyl diglycol dimaleate, which is present in varying concentrations across its product range — from in-salon treatments to at-home shampoos, conditioners, and bond-building treatments.
According to the manufacturer, the mechanism of action is based on the concept of disulphide bond repair. Hair structure relies heavily on disulphide bonds within the keratin protein chains. Chemical processes such as bleaching, colouring, and heat styling can break these bonds, leading to weakened, brittle, and porous hair. Olaplex products are designed to cross-link and reconnect these broken bonds, theoretically restoring structural integrity to the hair shaft. It is important to note that the majority of research supporting this mechanism has been conducted or funded by the brand itself; independent peer-reviewed evidence remains limited.
Olaplex acts primarily on the hair shaft itself — the visible, non-living portion of the hair — rather than on the scalp or hair follicle. This distinction is clinically important: true hair loss is a follicular process (the living root stops producing hair), whereas hair breakage is damage to the existing hair strand that can mimic shedding. Understanding this difference helps contextualise the ongoing debate around whether Olaplex could be associated with shedding or thinning, and underlines why any persistent or distressing hair loss should be assessed by a healthcare professional rather than attributed solely to a cosmetic product.
Not sure if this is normal? Chat with one of our pharmacists →
| Cause of Hair Loss | Type | Key Features | Relevant Investigation | When to Seek Help |
|---|---|---|---|---|
| Telogen effluvium | Temporary, diffuse shedding | Triggered by stress, illness, nutritional deficiency, or hormonal changes | Full blood count, serum ferritin, TSH | If shedding is rapid or persists beyond 3 months |
| Androgenetic alopecia | Genetic/hormonal, progressive | Most common form in men and women; gradual thinning pattern | Clinical assessment; bloods if indicated | If progressively worsening over several months |
| Alopecia areata | Autoimmune, patchy | Smooth, well-defined bald patches; can affect any scalp area | GP or NHS dermatologist assessment | On noticing patchy or uneven hair loss |
| Scarring alopecia (e.g., lichen planopilaris) | Inflammatory, potentially permanent | Smooth shiny patches, no visible follicular openings; scalp pain or redness | Urgent NHS dermatologist referral; possible biopsy | Promptly — follicle damage may be irreversible |
| Thyroid disorders | Systemic/hormonal, diffuse | Both hypothyroidism and hyperthyroidism cause diffuse thinning | TSH, free T4 | If hair loss accompanies fatigue, weight changes, or temperature intolerance |
| Iron deficiency anaemia | Nutritional, diffuse | Common in women of reproductive age; treatable cause of shedding | Full blood count, serum ferritin | If hair loss accompanies fatigue or pallor |
| Drug-induced alopecia | Medication-related, variable | Associated with antidepressants, anticoagulants, hormonal contraceptives | GP medication review | If hair loss began after starting a new medication |
What the Evidence Says About Olaplex and Hair Health
No robust, independent peer-reviewed evidence directly links Olaplex to hair loss; most supporting research has been conducted or funded by the brand itself.
At present, there is no robust, independent peer-reviewed clinical evidence directly linking Olaplex products to hair loss or significant scalp damage in the general population. The majority of published research on bis-aminopropyl diglycol dimaleate has been conducted or funded by the brand itself, which limits the independence and generalisability of those findings.
Some consumer reports and online communities have described experiences of increased hair shedding, scalp irritation, and changes in hair texture following use of Olaplex products — particularly the No. 3 Hair Perfector and No. 4 Bond Maintenance Shampoo. However, anecdotal reports do not constitute clinical evidence, and many individuals reporting hair loss may have pre-existing conditions or concurrent factors that better explain their symptoms.
A notable development came in 2022 when a class action lawsuit was filed in the United States alleging that certain Olaplex products caused hair loss and scalp damage. This prompted wider public concern. However, legal proceedings are not equivalent to scientific proof of causation, and the case has not resulted in any regulatory action by UK or European authorities.
A separate and frequently misunderstood issue concerns lilial (butylphenyl methylpropional), a fragrance ingredient previously used in some Olaplex products. Following a European Commission decision classifying lilial as a Category 1B reproductive toxicant, it was banned in cosmetics across the EU and UK from March 2022. Olaplex had already removed lilial from its formulations before the ban took effect. Crucially, this ban related to reproductive toxicity classification — not to hair loss — and should not be conflated with concerns about shedding or scalp damage.
Some commentators have raised questions about whether maleic acid derivatives — a component class related to the active ingredient — could potentially cause protein damage under certain conditions of use. This remains speculative and is not supported by robust published evidence; consumers should be cautious about drawing firm conclusions from preliminary or contested data.
Reported Side Effects and Regulatory Concerns in the UK
UK regulators including the OPSS and NHS have not issued formal safety warnings linking Olaplex to hair loss; adverse cosmetic reactions should be reported to the brand's Responsible Person or Trading Standards via Citizens Advice.
In the United Kingdom, cosmetic products including hair care treatments are regulated under the UK Cosmetics Regulation (retained from EU Regulation 1223/2009 following Brexit), overseen by the Office for Product Safety and Standards (OPSS). Cosmetics are not regulated by the Medicines and Healthcare products Regulatory Agency (MHRA), which covers medicines, vaccines, and medical devices.
As of the time of writing, neither the OPSS, the NHS, nor the European Commission's Scientific Committee on Consumer Safety (SCCS) has issued a formal safety warning specifically linking Olaplex products to hair loss.
Nonetheless, reported side effects from consumers have included:
Experiencing these side effects? Our pharmacists can help you navigate them →
-
Increased hair shedding or breakage
-
Scalp irritation, redness, or itching
-
Dry or brittle hair texture following prolonged use
-
Allergic contact dermatitis in sensitive individuals
- How to report a suspected reaction to a cosmetic product in the UK: If you experience an adverse reaction to a cosmetic product, you should:
- Stop using the product immediately.
- Contact the brand or its UK Responsible Person (the company legally accountable for the product's safety).
- Report concerns to Citizens Advice, who can refer the matter to Trading Standards.
- Healthcare professionals and businesses are required to report serious undesirable effects (SUEs) directly to the OPSS.
Note that the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) is for reporting suspected side effects from medicines, vaccines, and medical devices — not cosmetic products. If you suspect a reaction to a medicine or medical device, please use the Yellow Card scheme.
If you develop scalp irritation or a suspected allergic reaction, a patch test assessment by a dermatologist can help identify the causative ingredient. Persistent scalp irritation or unexplained hair loss should always be evaluated by a healthcare professional.
Other Common Causes of Hair Loss to Consider
Hair loss is multifactorial; common UK causes include telogen effluvium, androgenetic alopecia, thyroid disorders, and iron deficiency anaemia, all of which should be excluded before blaming a specific product.
Hair loss is a multifactorial condition, and it is clinically important not to attribute shedding or thinning to a single product without ruling out other well-established causes. In the UK, the most common forms of hair loss seen in primary care include:
-
Telogen effluvium — a temporary, diffuse shedding often triggered by physical or emotional stress, illness, nutritional deficiency, or hormonal changes (such as postpartum hair loss)
-
Androgenetic alopecia — the most prevalent form of hair loss in both men and women, driven by genetic and hormonal factors
-
Alopecia areata — an autoimmune condition causing patchy hair loss
-
Traction alopecia — caused by prolonged mechanical tension on the hair follicle from tight hairstyles
-
Scarring alopecias (e.g., lichen planopilaris, frontal fibrosing alopecia) — inflammatory conditions that can permanently damage follicles; these require prompt specialist assessment
-
Tinea capitis — a fungal scalp infection, particularly important to consider in children presenting with patchy hair loss, scaling, or lymphadenopathy
-
Thyroid disorders — both hypothyroidism and hyperthyroidism are well-recognised causes of diffuse hair thinning
-
Iron deficiency anaemia — a common and treatable cause, particularly in women of reproductive age
-
Nutritional deficiencies — low ferritin and vitamin D are the most clinically relevant; zinc and biotin deficiency are rare in the UK and are not routinely tested unless there is a specific clinical indication
Many individuals who begin using Olaplex products are also undergoing chemical hair treatments such as bleaching or colouring, which themselves can cause mechanical breakage that mimics hair loss. It is therefore essential to consider the full clinical picture — including diet, stress levels, medical history, medications, and hair care practices — before concluding that a specific product is responsible.
Certain medications, including some antidepressants, anticoagulants, and hormonal contraceptives, are also associated with hair shedding. A thorough medication review by a GP can help identify or exclude drug-induced alopecia.
A note on biotin supplements: If you are taking biotin (vitamin B7) supplements, inform your GP or clinician before blood tests are taken. The MHRA has issued a safety update confirming that biotin supplementation can interfere with a range of laboratory assays and may produce misleading results.
When to Seek Advice from a GP or Dermatologist
Consult a GP promptly if you experience sudden, patchy, or progressive hair loss, especially if accompanied by scalp inflammation, pain, or systemic symptoms such as fatigue or weight changes.
If you are concerned about hair loss — whether or not you believe it may be related to a hair care product such as Olaplex — it is important to seek professional advice rather than self-diagnose. A GP is the appropriate first point of contact and can carry out an initial assessment, including a review of your medical history, medications, and lifestyle factors.
You should contact your GP if you notice:
-
Sudden or rapid hair loss over a short period
-
Patchy or uneven hair loss across the scalp
-
Hair loss accompanied by scalp pain, redness, scaling, or inflammation
-
Thinning that is progressively worsening over several months
-
Hair loss alongside other symptoms such as fatigue, weight changes, or irregular periods
Seek prompt medical attention if you notice any of the following, as these may indicate conditions requiring urgent specialist assessment:
-
Smooth, shiny bald patches with no visible follicular openings (which may suggest scarring alopecia)
-
Scalp pain, persistent redness, or pustules alongside hair loss
-
Boggy, scaly, or inflamed patches in a child with associated lymph node swelling (which may suggest tinea capitis requiring antifungal treatment)
Your GP may arrange blood tests to investigate underlying causes. Commonly requested tests in UK primary care include a full blood count, serum ferritin, and thyroid function tests (TSH). Additional tests such as vitamin D, vitamin B12, or coeliac screen may be considered if clinically indicated. Routine testing for zinc or biotin is not standard practice in the UK unless there is a specific clinical reason.
For more complex or persistent cases, your GP may refer you to a NHS consultant dermatologist, who can diagnose and manage conditions such as alopecia areata, scarring alopecias, and androgenetic alopecia, with access to treatments including topical minoxidil, steroid injections, or immunotherapy where appropriate. You may also encounter trichologists — practitioners who specialise in hair and scalp conditions — but it is important to be aware that trichology is not a regulated medical profession in the UK. A trichologist cannot replace assessment and treatment by a qualified medical professional, and any serious or unexplained hair loss should be evaluated by a GP or NHS dermatologist in the first instance.
In summary, while there is no official regulatory link between Olaplex and hair loss in the UK, any unexplained or distressing hair shedding warrants proper clinical evaluation. Discontinuing a suspected product is a reasonable precautionary step, but professional assessment remains essential to identify and treat the true underlying cause.
Frequently Asked Questions
Has any UK regulatory body confirmed that Olaplex causes hair loss?
No. As of the time of writing, neither the Office for Product Safety and Standards (OPSS), the NHS, nor the MHRA has issued a formal safety warning linking Olaplex products to hair loss. Adverse reactions to cosmetic products should be reported to the brand's UK Responsible Person or via Citizens Advice to Trading Standards.
Why was lilial removed from Olaplex products, and is it related to hair loss?
Lilial (butylphenyl methylpropional) was banned in UK and EU cosmetics from March 2022 because it was classified as a Category 1B reproductive toxicant by the European Commission — not because of any link to hair loss. Olaplex removed lilial from its formulations before the ban came into effect.
When should I see a GP about hair loss rather than blaming a hair care product?
You should see a GP if you notice sudden, patchy, or progressively worsening hair loss, particularly if accompanied by scalp pain, redness, scaling, or systemic symptoms such as fatigue or irregular periods. A GP can arrange blood tests to investigate underlying causes such as thyroid disorders or iron deficiency anaemia.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript








